Revised SPC: Campto (irinotecan hydrochloride trihydrate) concentrate for solution for infusion- all strengths

Apalutamide has been added to list of strong inducers of CYP3A4 for which concomitant use with irinotecan should be avoided due to risk of affecting metabolism of irinotecan.

electronic Medicines compendium